Byung-Wan Lee - Search Results

Year	Number of Results
2005	4
2006	2
2007	4
2008	2
2009	6
2010	9
2011	12
2012	24
2013	9
2014	18
2015	14
2016	15
2017	29
2018	23
2019	26
2020	22
2021	13
2022	18
2023	17
2024	8

1

The Efficacy and Tolerability of Irbesartan/Amlodipine Combination Therapy in Patients With Essential Hypertension Whose Blood Pressure Were not Controlled by Irbesartan Monotherapy.

Lee HY, Min KW, Han KA, Kim JS, Ahn JC, Kim MH, Lee JB, Shin SH, Kim CJ, Kim KH, Cho DK, Choi J, Rhee MY, Her SH, Kim W, Na JO, Cho GY, Kim SY, Park GM, Lee BK, Jo SH, Lee BW, Sohn IS, Kim DI, Ihm SH, Lee SH, Chung JW, Cho EJ, Son JW, Oh SJ, Hwang JY, Jeong JO, Han KR, Yoon HJ, Seo SM, Chung WJ, Bae JW, Choi JH, Hyun BJ, Cha JE, Yoo SJ, Shin J. Lee HY, et al. Among authors: lee bw. Clin Ther. 2024 May 3:S0149-2918(24)00084-5. doi: 10.1016/j.clinthera.2024.04.004. Online ahead of print. Clin Ther. 2024. PMID: 38704294

2

A 52-week efficacy and safety study of enavogliflozin versus dapagliflozin as an add-on to metformin in patients with type 2 diabetes mellitus: ENHANCE-M extension study.

Sohn TS, Han KA, Kim Y, Lee BW, Chon S, Jeong IK, Hong EG, Son JW, Na J, Cho JM, In Cho S, Huh W, Yoon KH. Sohn TS, et al. Among authors: lee bw. Diabetes Obes Metab. 2024 Mar 8. doi: 10.1111/dom.15537. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 38456558

3

Corrigendum to "Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study" [Metabolism, Volume 152, March 2024, 155789].

Han E, Lee BW, Kang ES, Cha BS, Ahn SH, Lee YH, Kim SU. Han E, et al. Among authors: lee bw. Metabolism. 2024 May;154:155819. doi: 10.1016/j.metabol.2024.155819. Epub 2024 Feb 26. Metabolism. 2024. PMID: 38412589 No abstract available.

4

Safety and Effectiveness of Dulaglutide in the Treatment of Type 2 Diabetes Mellitus: A Korean Real-World Post-Marketing Study.

Han J, Lee WJ, Hur KY, Cho JH, Lee BW, Park CY. Han J, et al. Among authors: lee bw. Diabetes Metab J. 2024 Feb 2. doi: 10.4093/dmj.2023.0030. Online ahead of print. Diabetes Metab J. 2024. PMID: 38310883 Free article.

5

Intact ketogenesis predicted reduced risk of moderate-severe metabolic-associated fatty liver disease assessed by liver transient elastography in newly diagnosed type 2 diabetes.

Lee S, Bae J, Kim SU, Lee M, Lee YH, Kang ES, Cha BS, Lee BW. Lee S, et al. Among authors: lee bw. Front Endocrinol (Lausanne). 2024 Jan 8;14:1306134. doi: 10.3389/fendo.2023.1306134. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38260169 Free PMC article.

6

Dysregulation of autophagy activation induced by atorvastatin contributes to new-onset diabetes mellitus in western diet-fed mice.

Kim J, Kim M, Kim M, You YH, Song Y, Lee BW. Kim J, et al. Among authors: lee bw. Metabolism. 2024 Apr;153:155795. doi: 10.1016/j.metabol.2024.155795. Epub 2024 Jan 20. Metabolism. 2024. PMID: 38253121

7

Efficacy and Safety of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin as Metformin Add-on in a Korean Population with Type 2 Diabetes.

Lee BW, Cho YM, Kim SG, Ko SH, Lim S, Dahaoui A, Jeong JS, Lim HJ, Yu JM. Lee BW, et al. Diabetes Ther. 2024 Feb;15(2):547-563. doi: 10.1007/s13300-023-01515-0. Epub 2024 Jan 18. Diabetes Ther. 2024. PMID: 38236431 Free PMC article.

8

Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study.

Han E, Lee BW, Kang ES, Cha BS, Ahn SH, Lee YH, Kim SU. Han E, et al. Among authors: lee bw. Metabolism. 2024 Mar;152:155789. doi: 10.1016/j.metabol.2024.155789. Epub 2024 Jan 13. Metabolism. 2024. PMID: 38224909

9

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis.

Agarwal R, Tu W, Farjat AE, Farag YMK, Toto R, Kaul S, Lawatscheck R, Rohwedder K, Ruilope LM, Rossing P, Pitt B, Filippatos G, Anker SD, Bakris GL; FIDELIO-DKD and FIGARO-DKD Investigators. Agarwal R, et al. Ann Intern Med. 2023 Dec;176(12):1606-1616. doi: 10.7326/M23-1023. Epub 2023 Dec 5. Ann Intern Med. 2023. PMID: 38048573 Clinical Trial.

10

Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Predicts Hepatic Morbidities.

Han E, Lee YH, Ahn SH, Cha BS, Kim SU, Lee BW. Han E, et al. Among authors: lee bw. Gut Liver. 2023 Nov 28. doi: 10.5009/gnl230238. Online ahead of print. Gut Liver. 2023. PMID: 38013477 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

244 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

244 results

Results by year